Novavax (NVAX) Assets (2010 - 2026)
Novavax (NVAX) recorded Assets of $955.58 million in Q2 2026, down 28.5% from $1.34 billion a year earlier and down 8.4% from the prior quarter.
Powered by 
Analysis
Novavax (NVAX) Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Novavax reported Assets of $1.18 billion, down 24.6% from FY2024.
- Annual Assets has declined for four straight years, with a five-year compound annual growth rate of -5.8% (FY2020 to FY2025).
- Across earlier years, Assets came in at $1.56 billion in FY2024 (-13.2%), $1.8 billion in FY2023 (-20.4%), $2.26 billion in FY2022 (-12.3%) and $2.58 billion in FY2021 (+62.8%).
- The Q2 2026 figure is the lowest quarterly Assets since Q3 2020.
- On a year-over-year basis, Assets has declined for seven consecutive quarters, with an average decline of 18.0% over the last eight quarters.
- Peak year-over-year performance for Assets in the last five years was growth of 171.8% in Q3 2021, against a decline of 45.6% in Q1 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.04 billion (Q1 2026), $1.18 billion (Q4 2025) and $1.18 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Novavax | 1.78 Bn | -1.23 Bn | 42.45 Mn | 955.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 955.58 Mn |
| Mar 31, 2026 | 1.04 Bn |
| Dec 31, 2025 | 1.18 Bn |
| Sep 30, 2025 | 1.18 Bn |
| Jun 30, 2025 | 1.34 Bn |
| Mar 31, 2025 | 1.29 Bn |
| Dec 31, 2024 | 1.56 Bn |
| Sep 30, 2024 | 1.71 Bn |
| Jun 30, 2024 | 1.82 Bn |
| Mar 31, 2024 | 1.35 Bn |
| Dec 31, 2023 | 1.80 Bn |
| Sep 30, 2023 | 1.66 Bn |
| Jun 30, 2023 | 1.69 Bn |
| Mar 31, 2023 | 1.54 Bn |
| Dec 31, 2022 | 2.26 Bn |
| Sep 30, 2022 | 2.27 Bn |
| Jun 30, 2022 | 2.62 Bn |
| Mar 31, 2022 | 2.83 Bn |
| Dec 31, 2021 | 2.58 Bn |
| Sep 30, 2021 | 2.57 Bn |
API Access
Novavax Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=NVAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "NVAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=NVAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();